Frontiers in Immunology | Vaccines and Molecular Therapeutics

Brief Research Report

Published on 27 Jun 2025

Pre-clinical allergenicity assessment of IgE epitope-targeted Der p 2 mutants demonstrate potential as hypoallergenic AIT candidates

in Vaccines and Molecular Therapeutics

Glorismer Pena-Amelunxen
Mohadeseh Asghari
Kriti Khatri
Jill Glesner
Serge A. Versteeg
Ronald van Ree
Martin D. Chapman
Scott A. Smith
Maksymilian Chruszcz
Anna Pomés

Frontiers in Immunology

doi 10.3389/fimmu.2025.1623920

1,098 views

Original Research

Published on 26 Jun 2025

Nanolipoprotein particle (NLP) vaccine confers protection against Yersinia pestis aerosol challenge in a BALB/c mouse model

in Vaccines and Molecular Therapeutics

Sergei S. Biryukov
Amy Rasley
Michael L. Davies
Christopher P. Klimko
Jennifer L. Dankmeyer
Melissa Hunter
Nathaniel O. Rill
Jennifer L. Shoe
Jeremy Miller
Yuli Talyansky

Frontiers in Immunology

doi 10.3389/fimmu.2025.1603710

1,389 views

Original Research

Published on 26 Jun 2025

A consensus mathematical model of vaccine-induced antibody dynamics for multiple vaccine platforms and pathogens

in Vaccines and Molecular Therapeutics

Kristen M. Wilding
Carmen Molina-París
Jessica Z. Kubicek-Sutherland
Benjamin McMahon
Alan S. Perelson
Ruy M. Ribeiro

Frontiers in Immunology

doi 10.3389/fimmu.2025.1596518

1,036 views

Brief Research Report

Published on 26 Jun 2025

Sexual dimorphism-driven differences are overcome in a preclinical vaccine model against Trypanosoma cruzi

in Vaccines and Molecular Therapeutics

Camila Bulfoni Balbi
Maria Florencia Pacini
Brenda Dinatale
Cecilia Farré
Paula Cacik
Estefanía Prochetto
Florencia Belén González
Iván Marcipar
Gabriel Cabrera
Ana Rosa Pérez

Frontiers in Immunology

doi 10.3389/fimmu.2025.1526573

950 views

Brief Research Report

Published on 25 Jun 2025

Immune responses following DNA vaccination by needle-free injection against Burkholderia pseudomallei hemolysin co-regulated protein 1

in Vaccines and Molecular Therapeutics

Michael L. Davies
Sergei S. Biryukov
Christopher P. Klimko
Jennifer L. Dankmeyer
Nathaniel O. Rill
Melissa Hunter
Christopher T. Braun
Deven W. Patrick
Tyrique D. David
Steven A. Kwilas

Frontiers in Immunology

doi 10.3389/fimmu.2025.1612540

868 views

Review

Published on 25 Jun 2025

Progress in combination vaccines and the co-administration of influenza virus and SARS-CoV-2 vaccines

in Vaccines and Molecular Therapeutics

Chengyu Hu
Chenguang Niu
Xiaohui Li
Ke He
Mengyu Li
Xiaonan Gao
Qiannan Wei
Weiyang Sun
Yongkun Zhao
Yuanguo Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1578733

1,504 views

Review

Published on 24 Jun 2025

Melioidosis vaccines: recent advances and future directions

in Vaccines and Molecular Therapeutics

Sineenart Sengyee
Sarah B. Weiby
Ivory T. Rok
Mary N. Burtnick
Paul J. Brett

Frontiers in Immunology

doi 10.3389/fimmu.2025.1582113

1,254 views

Original Research

Published on 23 Jun 2025

Characterization of the clinical relevance and hypoallergenic peptides of the newly evidenced major allergen Hum j 1

in Vaccines and Molecular Therapeutics

Ya-Li Cheng
Qiong Li
Yong-Shi Yang
Yi-Bo Hou
Zhi-Qiang Xu
Ji-Fu Wei
Jin-Lyu Sun

Frontiers in Immunology

doi 10.3389/fimmu.2025.1588870

1,013 views

Original Research

Published on 23 Jun 2025

Correlation between microneutralization test and a multiplexed immunoassay for evaluation of monkeypox and vaccinia virus antibodies before and after smallpox vaccination

in Vaccines and Molecular Therapeutics

Serena Marchi
Giulia Piccini
Edmond J. Remarque
Giulia Roscia
Bianca Semplici
Paolo Cantaloni
Noemi Guerrini
Roberta Zannella
Rosa Coluccio
Linda Benincasa

Frontiers in Immunology

doi 10.3389/fimmu.2025.1585284

1,201 views

Original Research

Published on 20 Jun 2025

Comparison of homologous and heterologous vaccination strategies for combating disease caused by Burkholderia pseudomallei

in Vaccines and Molecular Therapeutics

Sergei S. Biryukov
Christopher K. Cote
Christopher P. Klimko
Jennifer L. Dankmeyer
Nathaniel O. Rill
Melissa Hunter
Michael L. Davies
Zander M. Hedrick
Jennifer L. Shoe
Lindsey K. Schmidt

Frontiers in Immunology

doi 10.3389/fimmu.2025.1596265

999 views

Original Research

Published on 20 Jun 2025

GMMA-based vaccine candidates against invasive nontyphoidal salmonellosis elicit bactericidal antibodies against a panel of epidemiologically relevant Salmonellae

in Vaccines and Molecular Therapeutics

Daniele De Simone
Marika Pinto
Maria Grazia Aruta
Marta Benincasa
Martina Carducci
Roberta Di Benedetto
Francesco Citiulo
Miren Iturriza
Elli Mylona
Stephen Baker

Frontiers in Immunology

doi 10.3389/fimmu.2025.1610067

851 views

Correction

Published on 19 Jun 2025

Correction: Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer

in Vaccines and Molecular Therapeutics

Yanan Tong
Guoxiu Lu
Zhiguo Wang
Shanhu Hao
Guoxu Zhang
Hongwu Sun

Frontiers in Immunology

doi 10.3389/fimmu.2025.1639717

572 views

Original Research

Published on 19 Jun 2025

Circular mRNA-LNP vaccine encoding self-assembled E2-TMD-mi3 nanoparticles licit enhanced CSFV-specific immunity over commercial subunit vaccine

in Vaccines and Molecular Therapeutics

Chunxi Liu
Weifeng Zhai
Wenhao Nie
Conghao Zhong
Feifei Diao
Bo Yin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1604677

1,238 views

Perspective

Published on 18 Jun 2025

Immunogenicity of therapeutic peptide products: bridging the gaps regarding the role of product-related risk factors

in Vaccines and Molecular Therapeutics

Montserrat Puig
Sophie Shubow

Frontiers in Immunology

doi 10.3389/fimmu.2025.1608401

1,390 views

Original Research

Published on 18 Jun 2025

Epidemiological characteristics of breakthrough varicella cases among students in Jiulongpo District, Chongqing: implications for vaccination strategies

in Vaccines and Molecular Therapeutics

Huixian Zhou
Qianjin Long
Hechuan Xie
Yuan Yao
Chunyan Deng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1594598

917 views

Editorial

Published on 17 Jun 2025

Editorial: Nanoparticle-based delivery systems on immunomodulation

in Vaccines and Molecular Therapeutics

Pedro Augusto Carvalho Costa
Pedro Pires Goulart Guimaraes

Frontiers in Immunology

doi 10.3389/fimmu.2025.1626027

974 views